These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18035558)

  • 21. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
    Scheinin NM; Aalto S; Koikkalainen J; Lötjönen J; Karrasch M; Kemppainen N; Viitanen M; Någren K; Helin S; Scheinin M; Rinne JO
    Neurology; 2009 Oct; 73(15):1186-92. PubMed ID: 19726751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging.
    Moon WJ; Park JY; Yun WS; Jeon JY; Moon YS; Kim H; Kwak KC; Lee JM; Han SH
    Korean J Radiol; 2016; 17(5):633-40. PubMed ID: 27587951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study.
    Palermo G; Tommasini L; Aghakhanyan G; Frosini D; Giuntini M; Tognoni G; Bonuccelli U; Volterrani D; Ceravolo R
    J Alzheimers Dis; 2019; 70(2):597-609. PubMed ID: 31256138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.
    Petrou M; Bohnen NI; Müller ML; Koeppe RA; Albin RL; Frey KA
    Neurology; 2012 Sep; 79(11):1161-7. PubMed ID: 22933741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
    Jokinen P; Scheinin N; Aalto S; Någren K; Savisto N; Parkkola R; Rokka J; Haaparanta M; Röyttä M; Rinne JO
    Parkinsonism Relat Disord; 2010 Dec; 16(10):666-70. PubMed ID: 20870446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.
    Gazzina S; Premi E; Turrone R; Acosta-Cabronero J; Rizzetti MC; Cotelli MS; Gasparotti R; Padovani A; Borroni B
    J Neurol; 2016 Aug; 263(8):1575-82. PubMed ID: 27230856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
    Bacskai BJ; Frosch MP; Freeman SH; Raymond SB; Augustinack JC; Johnson KA; Irizarry MC; Klunk WE; Mathis CA; Dekosky ST; Greenberg SM; Hyman BT; Growdon JH
    Arch Neurol; 2007 Mar; 64(3):431-4. PubMed ID: 17353389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
    Villemagne VL; Okamura N; Pejoska S; Drago J; Mulligan RS; Chételat G; O'Keefe G; Jones G; Kung HF; Pontecorvo M; Masters CL; Skovronsky DM; Rowe CC
    Neurodegener Dis; 2012; 10(1-4):161-5. PubMed ID: 22261520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT.
    Song IU; Chung YA; Chung SW; Jeong J
    Dement Geriatr Cogn Disord; 2014; 37(5-6):276-85. PubMed ID: 24356537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional cerebral blood flow in Parkinson's disease with and without dementia.
    Firbank MJ; Colloby SJ; Burn DJ; McKeith IG; O'Brien JT
    Neuroimage; 2003 Oct; 20(2):1309-19. PubMed ID: 14568499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of PiB binding to white matter in Alzheimer disease and other dementias.
    Fodero-Tavoletti MT; Rowe CC; McLean CA; Leone L; Li QX; Masters CL; Cappai R; Villemagne VL
    J Nucl Med; 2009 Feb; 50(2):198-204. PubMed ID: 19164220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
    Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.
    Colloby SJ; O'Brien JT; Fenwick JD; Firbank MJ; Burn DJ; McKeith IG; Williams ED
    Neuroimage; 2004 Nov; 23(3):956-66. PubMed ID: 15528096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.